KR920701445A - 쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26 - Google Patents

쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26

Info

Publication number
KR920701445A
KR920701445A KR1019910701272A KR910701272A KR920701445A KR 920701445 A KR920701445 A KR 920701445A KR 1019910701272 A KR1019910701272 A KR 1019910701272A KR 910701272 A KR910701272 A KR 910701272A KR 920701445 A KR920701445 A KR 920701445A
Authority
KR
South Korea
Prior art keywords
protein
amino acid
sequence
acid sequence
fragment
Prior art date
Application number
KR1019910701272A
Other languages
English (en)
Korean (ko)
Inventor
트로뗑 프랑스와
까프롱 앙드레
슈미트 도리스
로꼬끄 쟝-삐에르
Original Assignee
원본미기재
트랑스젠느 에스 아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 트랑스젠느 에스 아 filed Critical 원본미기재
Publication of KR920701445A publication Critical patent/KR920701445A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR1019910701272A 1990-02-07 1991-02-06 쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26 KR920701445A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR90/01403 1990-02-07
FR9001403A FR2657883A1 (de) 1990-02-07 1990-02-07
PCT/FR1991/000091 WO1991012327A1 (fr) 1990-02-07 1991-02-06 Glutathion-s-transferase sm26 de s. mansoni

Publications (1)

Publication Number Publication Date
KR920701445A true KR920701445A (ko) 1992-08-11

Family

ID=9393459

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910701272A KR920701445A (ko) 1990-02-07 1991-02-06 쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26

Country Status (7)

Country Link
EP (1) EP0466912A1 (de)
JP (1) JPH04505402A (de)
KR (1) KR920701445A (de)
AU (1) AU645786B2 (de)
CA (1) CA2051695A1 (de)
FR (1) FR2657883A1 (de)
WO (1) WO1991012327A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995035370A1 (en) * 1994-06-22 1995-12-28 Imperial College Of Science Technology & Medicine Schistosoma protein and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU613583B2 (en) * 1986-08-22 1991-08-08 Transgene S.A. Proteins and the method for preparing them, DNA sequences, antibodies and their application, poxviruses, transformed or infected cells, pharmaceutical compositions which are useful in the prevention of schistosomiasis and application by way of an agent possessing glutathione s-transferase activity
NZ224663A (en) * 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors
JPH04507235A (ja) * 1989-01-31 1992-12-17 ダラテック　ピーテーワイ　リミテッド 反芻動物における肝吸虫感染に対する予防治療のためのワクチン

Also Published As

Publication number Publication date
AU645786B2 (en) 1994-01-27
FR2657883A1 (de) 1991-08-09
CA2051695A1 (fr) 1991-08-08
JPH04505402A (ja) 1992-09-24
AU7333391A (en) 1991-09-03
WO1991012327A1 (fr) 1991-08-22
EP0466912A1 (de) 1992-01-22

Similar Documents

Publication Publication Date Title
Gustafson et al. Isolation, primary sequence determination, and disulfide bond structure of cyanovirin-N, an anti-HIV (human immunodeficiency virus) protein from the CyanobacteriumNostoc ellipsosporum
DK714788A (da) Polypeptider og derivater deraf samt deres anvendelse i pharmaceutiske og diagnostiske praeparater
KR890003802A (ko) 재조합 dna 기술에 의해 제조된 소의 췌장 트립신 억제제, 그 제조 방법, 발현 벡터 및 재조합 숙주 및 그의 제약적 용도
DK305885D0 (da) Tumornecrosefaktor og derivater og mutantformer deraf, frem. til frems. deraf, frem. til isolering deraf fra en blanding med andre proteiner,praeparater deraf, dna som koder derfor, dna'en inkorporeret i en replicerbar vektor og celle transformeret dermed
RU95115239A (ru) Аналог эритропоэтина
DE69333802T8 (de) Äusseres membranprotein von haemophilus
RU93046317A (ru) Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции
ATE80180T1 (de) Herstellung eines igg-bindenden proteins zum erleichtern der weiterverarbeitung mittels ''protein-engineering''.
DK79190A (da) Praktisk taget rent polypeptid og dets anvendelse; rekombinantvirus, rekombinantvirus, rekomninant-dna-vektor og encellet organisme til dets fremstilling
BR9809445A (pt) Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico.
BR9712518A (pt) Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico
DE3066654D1 (en) Acyl peptides and pharmaceutical preparations thereof, as well as their manufacture and use
KR880009125A (ko) 재조합 숙주에 의해 제조되는 췌장분비 트립신 억제제 및 그의 변이체, 그의 방법, 표현벡터 및 재조합 숙주 및 그의 제약상 용도
DK100487A (da) Hidtil ukendte carbonsyrederivater, fremgangsmaade til deres fremstilling, deres anvendelse samt laegemidler indeholdende disse forbindelser
BR9803960A (pt) Gene de desidrogenase de d-sorbitol.
BR112022011975A2 (pt) Polipeptídeo de interferon-¿2 modificado, polipeptídeo gmop-interferon-¿2 modificado, ácido nucleico, plasmídeo, vetor, linha de célula, método para purificação do polipeptídeo de interferon-¿2 modificado, composição farmacêutica, método para uso de um ou mais dos polipeptídeos de interferon-¿2 modificados e método para tratar uma condição médica em um indivíduo
Kramps et al. The polypeptide chains of α-crystallin from old human eye lenses
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
Georges et al. Chemical modification of charged amino acid moieties alters the electrophoretic mobilities of neurofilament subunits on SDS/polyacrylamide gels
Fujimoto et al. Intraspecies composition difference in collagen from cuticle and body of Ascaris and Lumbricus
AMMER et al. The major protamine from stallion sperm. Isolation and amino-acid sequence
KR920701445A (ko) 쉬스토조마 맨소니의 글루타티온 에스-전이효소 sm26
ES2114555T3 (es) Nuevo interferon gamma humano recombinado.
KR880009127A (ko) 용성 성숙 hIL-β 및 변경된 생물학적 활성을 갖는 유도체를 이 콜라이에서 고도로 발현시키는 플라즈미드 및 그 방법
DK270489A (da) Protein med thrombininhiberende virkning, fremgangsmaade til dets isolering, samt dets anvendelse som laegemiddel

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid